Loading…
DNA-capped FeO/SiO magnetic mesoporous silica nanoparticles for potential controlled drug release and hyperthermia
We proposed a strategy to construct DNA-capped Fe 3 O 4 /SiO 2 magnetic mesoporous silica (MMS) nanoparticles for potential temperature controlled drug release and magnetic hyperthermia. Drug release behavior, magnetic heating capacity, in vitro cytotoxicity, and cell uptake of the MMS-based nanocar...
Saved in:
Published in: | RSC advances 2015-02, Vol.5 (29), p.22365-22372 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | We proposed a strategy to construct DNA-capped Fe
3
O
4
/SiO
2
magnetic mesoporous silica (MMS) nanoparticles for potential temperature controlled drug release and magnetic hyperthermia. Drug release behavior, magnetic heating capacity,
in vitro
cytotoxicity, and cell uptake of the MMS-based nanocarriers were evaluated. The results showed that the DOX/MMS-NH
2
-dsDNA complexes could release DOX fast at 50 °C, but very slow at 37 °C. Also, MMS-based nanocarriers could efficiently generate heat upon exposure to an alternating magnetic field due to the superparamagnetic behavior. Furthermore, the MMS-NH
2
-dsDNA complexes could be effectively taken up by murine breast cancer 4T1 cells, and negligible cytotoxicity of the MMS-NH
2
-dsDNA complexes has been observed. Therefore, DNA-capped MMS nanoparticles had potential for cancer therapy with temperature controlled drug release and magnetic hyperthermia.
DNA-capped Fe
3
O
4
/SiO
2
magnetic mesoporous silica (MMS) nanoparticles were developed for potential temperature controlled drug release and magnetic hyperthermia. |
---|---|
ISSN: | 2046-2069 |
DOI: | 10.1039/c5ra00701a |